Prothena Corp Public Ltd Co
Prothena develops therapeutic antibodies and protein-based treatments for neurodegenerative and amyloid diseases.
SCHEDULE 13G/AAug 19Latest SEC filing
Aug 6Latest story
August 2026
Sign inSign inProthena develops therapeutic antibodies and protein-based treatments for neurodegenerative and amyloid diseases.